SKI Market

A+| A| A-|

Indian Indices

Sensex

77,285.10 2,668.52
( 3.58%)

Global Indices

Nasdaq

46,614.19 -76.70
(-0.16%)

Dow Jones

6,639.23 6.40
(0.10%)

Hang Seng

53,529.44 115.76
(0.22%)

Nikkei 225

10,352.49 -83.80
(-0.80%)

Forex

USD-INR

92.93 0.25
(0.27%)

EUR-INR

107.23 0.49
(0.46%)

GBP-INR

122.94 0.71
(0.58%)

JPY-INR

0.58 0.00
(0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Manappuram Finance Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

531213

INE522D01027

147.4824522

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MANAPPURAM

13.85

21656.03

EPS(TTM)

Face Value()

Div & Yield %

18.47

1.56

Back

rril ltd

Ajanta Pharma consolidated net profit rises 17.56% in the December 2025 quarter

Jan 30,2026

Net profit of Ajanta Pharma rose 17.56% to Rs 273.77 crore in the quarter ended December 2025 as against Rs 232.88 crore during the previous quarter ended December 2024. Sales rose 19.95% to Rs 1374.84 crore in the quarter ended December 2025 as against Rs 1146.13 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1374.84	1146.13	20
OPM %	27.80	27.99	-
PBDT	402.11	343.36	17
PBT	358.60	307.39	17
NP	273.77	232.88	18

77,285.10 2,668.52 ( 3.58%)

46,614.19 -76.70 (-0.16%)

6,639.23 6.40 (0.10%)

53,529.44 115.76 (0.22%)

10,352.49 -83.80 (-0.80%)

92.93 0.25 (0.27%)

107.23 0.49 (0.46%)

122.94 0.71 (0.58%)

0.58 0.00 (0.32%)